Shell Asset Management Co. Buys 7,824 Shares of The Clorox Company $CLX

Shell Asset Management Co. grew its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 94.8% in the 2nd quarter, Holdings Channel.com reports. The fund owned 16,079 shares of the company’s stock after acquiring an additional 7,824 shares during the period. Shell Asset Management Co.’s holdings in Clorox were worth $1,931,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. American National Bank & Trust increased its holdings in shares of Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares in the last quarter. Ransom Advisory Ltd bought a new position in shares of Clorox during the first quarter valued at $35,000. GW&K Investment Management LLC increased its holdings in shares of Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after acquiring an additional 208 shares in the last quarter. Roble Belko & Company Inc increased its holdings in Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after buying an additional 211 shares in the last quarter. Finally, IMA Advisory Services Inc. bought a new stake in Clorox in the 1st quarter worth about $58,000. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on CLX. JPMorgan Chase & Co. lifted their price objective on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Wells Fargo & Company reduced their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. Bank of America reduced their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, TD Cowen cut their price target on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus price target of $132.92.

View Our Latest Analysis on CLX

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is owned by company insiders.

Clorox Trading Down 0.7%

Clorox stock opened at $119.59 on Thursday. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a market cap of $14.63 billion, a P/E ratio of 18.34, a P/E/G ratio of 0.98 and a beta of 0.52. The business has a 50-day simple moving average of $122.38 and a two-hundred day simple moving average of $129.11.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the previous year, the firm earned $1.82 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.